Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets
ACS Pharmacology & Translational Science · 13.02.2026 · 9 (2) · 332-347
DOI: 10.1021/acsptsci.5c00430 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 27.01.2026. Verfasst von Muhammad Rafehi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutscher Akademischer Austauschdienst, Deutsche Forschungsgemeinschaft, Universit??tsmedizin G??ttingen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Clinical Pharmacology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany.
- Faculty of Medicine, University of Augsburg and University Hospital of Augsburg, Am Medizincampus 2, 86156 Augsburg, Germany.
- Lübeck Institute of Experimental Dermatology (LIED), Medicinal Chemistry and Systems Polypharmacology, University of Lübeck and University Medical Center Schleswig-Holstein (UKSH), Ratzeburger Allee 160, 23538 Lübeck, G…
- Department of Pathology, Rikshospitalet, University of Oslo and Oslo University Hospital, Sognsvannsveien 20, 0372 Oslo, Norway.
- Lübeck Institute of Experimental Dermatology (LIED), Medical Systems Biology, University of Lübeck and University Medical Center Schleswig-Holstein (UKSH), Ratzeburger Allee 160, 23538 Lübeck, Germany.
- Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
ORCID-Profile: Muhammad Rafehi, Katja Stefan, Wouroud Ismail Al-Khalil, Jörg König, Sven Marcel Stefan
Förderung
- Deutscher Akademischer Austauschdienst
- Deutsche Forschungsgemeinschaft
- Universit??tsmedizin G??ttingen
- Narodowym Centrum Nauki
Zitieren
APA
Rafehi, M., Tägl, F., Arlt, N. S., Neif, M., Stefan, K., Ismail Al-Khalil, W., Busch, H., Möller, M., König, J., Namasivayam, V., & Stefan, S. M. (2026). Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets. ACS Pharmacology & Translational Science, 9(2), 332-347. https://doi.org/10.1021/acsptsci.5c00430
Vancouver
Rafehi M, Tägl F, Arlt NS, Neif M, Stefan K, Ismail Al-Khalil W, et al. Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets. ACS Pharmacology & Translational Science. 2026;9(2):332-347. doi:10.1021/acsptsci.5c00430
BibTeX
@article{Rafehi2026,
author = {Rafehi, Muhammad and Tägl, Franziska and Arlt, Nike Sophia and Neif, Maria and Stefan, Katja and Ismail Al-Khalil, Wouroud and Busch, Hauke and Möller, Marius and König, Jörg and Namasivayam, Vigneshwaran and Stefan, Sven Marcel},
title = {Target Class Repurposing Across Membrane Transporter Families Provides Privileged Ligands to Address Specific and Undruggable Pharmacological Targets},
journal = {ACS Pharmacology & Translational Science},
year = {2026},
volume = {9},
number = {2},
pages = {332--347},
doi = {10.1021/acsptsci.5c00430}
}
EUVIMED